MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) has released an update.
BioPharma Services, a subsidiary of HEALWELL AI Inc., is advancing its clinical research capabilities by moving into late-stage patient trials and integrating with AI technology. This strategic development transforms BioPharma into a full-service Contract Research Organization, supporting HEALWELL’s vision for growth and innovation in healthcare.
For further insights into TSE:AIDX stock, check out TipRanks’ Stock Analysis page.